Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation

Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation

Pentraxin-3 (PTX3) is an inflammatory marker thought to be more specific to cardiovascular inflammation than C-reactive protein (CRP). Our aim was to assess the prognostic value of PTX3 in patients with stable coronary artery disease (CAD) after drug eluting stent (DES) implantation. Plasma PTX3 lev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liu Haibo, Guo Xiaofang, Wang Chunming, Yuan Jie, Chen Guozhong, Zhang Limei, Cao Yong, Fang Yu, Bao Yingchun, Yu Wangjun, Ge Junbo
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2014/963096
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01)

Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation
by: Min-Tao Gai, et al.
Published: (2025-01-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
by: Kazunori Horie, MD, et al.
Published: (2025-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
by: Daisuke Kitano, et al.
Published: (2025-03-01)

Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents
by: Amir F. Mohani, et al.
Published: (2018-01-01)

Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
by: Robert J. Gil, et al.
Published: (2020-01-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
by: Tingting Wei, et al.
Published: (2022-06-01)

Advantages and disadvantages of coronary drug-eluting stent: a 23-year journey of randomized clinical trials
by: Alfredo E. Rodriguez, et al.
Published: (2024-07-01)

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation
by: Adam Peddle, et al.
Published: (2018-09-01)

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport
by: Tuoi Vo, et al.
Published: (2017-03-01)

A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure
by: Kun Wang, et al.
Published: (2022-06-01)

Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
by: Nicolas W. Shammas, et al.
Published: (2013-01-01)

Patient Safety Events Related to the Placement of Drug-Eluting Stents
by: Patient Safety Authority
Published: (2023-12-01)

Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01)

Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model
by: Masayuki Mori, et al.
Published: (2020-01-01)

The Predictive Value of the Pentraxin 3 Concentration in Cumulus Cell Culture Media for the Embryo Implantation
by: Tulay Irez, et al.
Published: (2022-08-01)

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
by: Chun Shing Kwok, et al.
Published: (2014-01-01)

Acute Coronary Syndrome after 17 Years of Bare Metal Stent Implantation: “Very” Very Late Stent Thrombosis
by: Raghavendra Rao K, et al.
Published: (2020-01-01)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

The prognostic association of triglyceride-glucose index and its derived indicators with stable coronary artery disease patients undergoing percutaneous coronary intervention
by: Yu Shan, et al.
Published: (2025-01-01)

Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
by: Zhongxia Wang, et al.
Published: (2016-01-01)

Stabilizing Stable Coronary Artery Disease
by: Kuan-Yu Chi, MD, et al.
Published: (2025-02-01)

Contrastive learning with transformer for adverse endpoint prediction in patients on DAPT post-coronary stent implantation
by: Fang Li, et al.
Published: (2025-01-01)

Effect of high-quality nursing interventions on the quality of life and cardiac index in acute coronary syndrome patients treated with drug-eluting stents: a randomized trial study
by: Zeinab Abdollahifar, et al.
Published: (2025-01-01)

Acute Thrombotic Occlusion of Right Coronary and Left Circumflex Coronary Arteries in a Patient with Antiphospholipid Syndrome: Successful Stent Implantation
by: Serdar Biceroglu, et al.
Published: (2010-01-01)

Serum VEGF: Diagnostic Value of Acute Coronary Syndrome from Stable Angina Pectoris and Prognostic Value of Coronary Artery Disease
by: Anan Huang, et al.
Published: (2020-01-01)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
by: Zhongxia Wang, et al.
Published: (2019-01-01)

Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study
by: Hao-Yu Wang, et al.
Published: (2020-01-01)

Sirolimus-Eluting Balloon for the Treatment of Coronary Lesions in Complex ACS Patients: The SELFIE Registry
by: Gianluca Caiazzo, et al.
Published: (2020-01-01)

Impact of gratitude on posttraumatic growth in patients with coronary stent implantation: the mediating role of resilience and perceived social support
by: Shanyan Lei, et al.
Published: (2025-01-01)

Low Resolution Limits and Inaccurate Algorithms Decrease Significantly the Value of Late Loss in Current Drug-Eluting Stent Trials
by: Johannes B. Dahm, et al.
Published: (2012-01-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
by: Kyle Murnaghan, et al.
Published: (2022-01-01)

Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison
by: Nathan Marzlin, et al.
Published: (2022-01-01)

Interfacing exogenous stents with human coronary artery by self-assembled coating: designs, functionalities and applications
by: Feng Zhao, et al.
Published: (2024-05-01)

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
by: You-Jeong Ki, et al.
Published: (2020-01-01)